Randomized, controlled clinical trial of glargine insulin versus ultralente insulin in type 1 diabetes

被引：0
|
作者：
Kudva, Y
Basu, A
Jenkins, G
Pons, G
Quandt, L
Gebel, J
Vogelsang, D
Smith, S
Isley, W
Rizza, R
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [31] Inhaled insulin plus insulin glargine versus biaspart insulin for type 2 diabetes
    不详
    AFRICAN JOURNAL OF DIABETES MEDICINE, 2010, 18 (02): : 18 - 18
  • [32] Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes A randomized controlled trial
    Logtenberg, Susan J.
    Kleefstra, Nanne
    Houweling, Sebastiaan T.
    Groenier, Klaas H.
    Gans, Reinold O.
    van Ballegooie, Evert
    Bilo, Henk J.
    DIABETES CARE, 2009, 32 (08) : 1372 - 1377
  • [33] Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III, randomized, open-label, controlled trial
    Feng, Wenhuan
    Chen, Wei
    Jiang, Shan
    Du, Liying
    Zhu, Dalong
    DIABETES OBESITY & METABOLISM, 2021, 23 (08): : 1786 - 1794
  • [34] Effects of Insulin Detemir Versus Insulin Glargine on Intake and Satiety Factors in Type 1 Diabetes
    Garimella, Madhavi
    Mitchell, Stephen
    Burge, Mark R.
    DIABETES, 2011, 60 : A687 - A687
  • [35] Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naive people with type 2 diabetes: The EDITION AP randomized controlled trial
    Ji, Linong
    Kang, Eun Seok
    Dong, XiaoLin
    Li, Ling
    Yuan, GuoYue
    Shang, Shuhua
    Niemoeller, Elisabeth
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 612 - 621
  • [36] Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes
    Schober, E
    Schoenle, E
    Van Dyk, J
    Wernicke-Panten, K
    DIABETES CARE, 2001, 24 (11) : 2005 - 2006
  • [37] A randomized controlled trial of insulin detemir versus insulin NPH for the treatment of pregnant women with gestational diabetes and type 2 diabetes
    Herrera, Kimberly
    Rosenn, Barak
    Foroutan, Janelle
    Bimson, Brianne
    Al Ibraheemi, Zainab
    Brustman, Lois
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (01) : S320 - S320
  • [38] Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
    Buse, John B.
    Rodbard, Helena W.
    Serrano, Carlos Trescoli
    Luo, Junxiang
    Ivanyi, Tibor
    Bue-Valleskey, Juliana
    Hartman, Mark L.
    Carey, Michelle A.
    Chang, Annette M.
    DIABETES CARE, 2016, 39 (01) : 92 - 100
  • [39] Basal Insulin Substitution with Glargine or CSII in Adult Type I Diabetes Patients-A Randomized Controlled Trial
    Bragd, Joakim
    Adamson, Ulf
    Lins, Per-Eric
    Von Dobeln, Anna
    Oskarsson, Per
    DIABETES, 2009, 58 : A60 - A61
  • [40] Once daily initiation with biphasic insulin aspart 30 (BIAsp 30) versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs - a randomized controlled trial
    Franek, E.
    Kalra, S.
    Pesic, M.
    Smahelova, A.
    Thomsen, H.
    Strojek, K.
    DIABETOLOGIA, 2009, 52 : S93 - S93
12345